Ignite Creation Date:
2024-05-06 @ 1:19 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01775462
Status:
COMPLETED
Last Update Posted:
2016-01-20
First Post:
2013-01-17
Brief Title:
Phase 2 Study to Evaluate Safety Pharmacokinetics Immunogenicity and PharmacodynamicsEfficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia XLHED
Sponsor:
Edimer Pharmaceuticals
Organization:
Edimer Pharmaceuticals
Organization Data
Organization:
Edimer Pharmaceuticals
Class:
INDUSTRY
Study ID:
ECP-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Edimer Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None